WGS CIK: 1818331

GeneDx Holdings Corp.

  • United States
  • Healthcare
  • MedTech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−16.6
FY22:
−26.8
FY23:
90.0
FY24:
194
FY25:
298
(positive)
Change from FY21 to FY25
millions USD
FY21:
−446
FY22:
−668
FY23:
−181
FY24:
−23.2
FY25:
−13.1
(positive)
Change from FY21 to FY25
millions USD
FY21:
−419
FY22:
–
FY23:
–
FY24:
12.1
FY25:
13.4
(positive)
Change from FY21 to FY25
millions USD
FY21:
−245
FY22:
−598
FY23:
−177
FY24:
−52.6
FY25:
−21.1
(positive)
Change from FY21 to FY25
millions USD
FY21:
−245
FY22:
−549
FY23:
−176
FY24:
−52.3
FY25:
−21.0

All amounts in millions USD Data sources:SEC EDGARTwelve Data